Delivery Order SPE2DE21D7010-SPE2D626F67J3
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $1,839.63 for allograft products on November 25, 2025, with an ultimate completion date of December 23, 2025. This fixed-price contract with economic price adjustment was funded by the Defense Logistics Agency Medical Supply Chain, a defense-focused federal agency responsible for procuring medical supplies and equipment...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $1,956.60 on December 12, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by January 6, 2026, and involves the supply of MAXCESS spinal surgical products and related medical devices to support federal...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a $2,438.82 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency Medical Supply Chain on December 10, 2025, for ultimate completion by December 11, 2025. This delivery order, designated as contract M5, carries no set-aside restrictions and represents an open market procurement. The award funds the supply of...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $5,204.05 on November 14, 2025, by the Defense Logistics Agency Medical Supply Chain. This fixed-price delivery order with economic price adjustment provisions is for the supply of LEVERAGE LFS spinal medical devices and related surgical instruments, with performance to be completed by December 5, 2025, at Nuvasive's...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $9,642.60 by the Defense Logistics Agency Medical Supply Chain on December 11, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting successful competition in an open market procurement. The award is scheduled for completion by January 2, 2026, with...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a $1,823.20 delivery order (Contract No. 4570097953) by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, for allograft products. The contract represents a firm fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of December 3, 2025. This award was made without set-aside...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order (Contract No. 4570300073) valued at $2,009.60 by the Defense Logistics Agency Medical Supply Chain on December 12, 2025. The contract covers the delivery of MAXCESS spinal surgical products and related medical devices to support Department of Defense and Department of Veterans Affairs healthcare operations. Structured as a firm...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order valued at $3,220.96 for COROENT SMALL INTERLOCK spinal implant products on October 30, 2025. This fixed-price delivery order with economic price adjustment provisions is funded through the Defense Logistics Agency Medical Supply Chain, a defense-focused entity responsible for procuring medical supplies and equipment for...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $21,266.40 by the Defense Logistics Agency (DLA) Medical Supply Chain on December 10, 2025. This firm fixed-price delivery order with economic price adjustment mechanisms is scheduled for completion by December 31, 2025, and will be performed at Nuvasive's San Diego facility. The contract carries no set-aside designation, reflecting Nuvasive's...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a $3,650.98 fixed-price delivery order with economic price adjustment (Contract No. 4570280058, "ARCHON DEGENERATIVE") by the Defense Logistics Agency Medical Supply Chain on November 26, 2025. The delivery order, with a completion date of January 5, 2026, represents a competitive open-market procurement without set-aside designation,...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F67J3Delivery Order
Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, was awarded a delivery order for allograft products valued at $1,367.40 by the Defense Logistics Agency Medical Supply Chain on December 30, 2025, with an ultimate completion date of January 21, 2026. This fixed-price contract with economic price adjustment mechanisms was issued without set-aside restrictions, reflecting Nuvasive's competitive standing in open market federal procurements. The performance location is designated as San Diego, California, where Nuvasive manufactures and delivers specialized spinal and orthopedic surgical technologies to support Department of Defense and Department of Veterans Affairs healthcare facilities. This delivery order is issued against the larger $8 million Blanket Purchase Agreement (BPA) established between Transplant Technology Inc. and the Defense Health Agency, structured as an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle effective through March 2027. Through this strategic framework and related DLA Medical Supply Chain contracts, Nuvasive provides critical bone graft materials and comprehensive spinal fusion systems, implants, surgical instruments, and biologics that support advanced orthopedic and neurosurgical procedures across military and veteran healthcare systems nationwide. Nuvasive's product portfolio includes specialized systems such as OSTEOCEL PRO, PROPEL DBM, and various interbody implants and accessory instruments, demonstrating sustained capability in delivering essential medical technologies that support operational readiness and medical mission effectiveness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/29/25 |